When.com Web Search

  1. Ads

    related to: human normal immunoglobulin therapy
    • View FAQs

      Find Answers To Common Questions

      You May Have About ZILBRYSQ®.

    • Vaccination Requirements

      Before Starting Treatment, View The

      REMS And Vaccination Requirements.

Search results

  1. Results From The WOW.Com Content Network
  2. Immunoglobulin therapy - Wikipedia

    en.wikipedia.org/wiki/Immunoglobulin_therapy

    Immunoglobulin therapy is the use of a mixture of antibodies (normal human immunoglobulin) to treat several health conditions. [13] [14] These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain–Barré syndrome, and certain other infections when a ...

  3. Rho(D) immune globulin - Wikipedia

    en.wikipedia.org/wiki/Rho(D)_immune_globulin

    Rho(D) immune globulin is made up of antibodies to the antigen Rh o (D) present on some red blood cells. [2] It is believed to work by blocking a person's immune system from recognizing this antigen. [2] Rh o (D) immune globulin came into medical use in the 1960s, [4] following the pioneering work of John G. Gorman.

  4. Polyclonal antibodies - Wikipedia

    en.wikipedia.org/wiki/Polyclonal_antibodies

    Rho(D) immune globulin is made from pooled human plasma provided by Rh-negative donors with antibodies to the D antigen. It is used to provide passive immune binding of antigen, preventing a maternal active immune response which could potentially result in hemolytic disease of the newborn .

  5. Immunotherapy - Wikipedia

    en.wikipedia.org/wiki/Immunotherapy

    Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapy is designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies .

  6. Killer-cell immunoglobulin-like receptor - Wikipedia

    en.wikipedia.org/wiki/Killer-cell_immunoglobulin...

    The Killer-cell immunoglobulin-like receptors (KIR) are being explored [28] [29] [30] as an alternative activation method in CAR T cell therapy. Unlike the traditional approach that utilizes T cell receptors, incorporating KIRs into CAR T cells aims to exploit the cytotoxic properties and regulatory functions of natural killer (NK) cells.

  7. Monoclonal antibody therapy - Wikipedia

    en.wikipedia.org/wiki/Monoclonal_antibody_therapy

    The advantage of active monoclonal antibody therapy is the fact that the immune system will produce antibodies long-term, with only a short-term drug administration to induce this response. However, the immune response to certain antigens may be inadequate, especially in the elderly.

  1. Ad

    related to: human normal immunoglobulin therapy